Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.11 and traded as low as $0.49. Accelerate Diagnostics shares last traded at $0.53, with a volume of 349,583 shares changing hands.
Analysts Set New Price Targets
Separately, StockNews.com upgraded Accelerate Diagnostics from a “sell” rating to a “hold” rating in a research note on Friday, February 17th.
Accelerate Diagnostics Trading Up 5.2 %
The firm has a 50 day moving average price of $0.64 and a 200-day moving average price of $1.11. The firm has a market cap of $43.23 million, a PE ratio of -0.55 and a beta of 1.12.
Hedge Funds Weigh In On Accelerate Diagnostics
Accelerate Diagnostics Company Profile
Accelerate Diagnostics, Inc is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
- Get a free copy of the StockNews.com research report on Accelerate Diagnostics (AXDX)
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
- Taiwan Semiconductor Manufacturing Expanding in the West
Receive News & Ratings for Accelerate Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accelerate Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.